• RESTRICT-seq Unveils KAT6A/B Dependencies in SCC Resistance

  2026-06-12

  The referenced study introduces RESTRICT-seq, a method for time-gated CRISPR screening, enabling the identification of previously unappreciated epigenetic dependencies in squamous cell carcinoma (SCC) resistance. Its innovative approach highlights the key role of KAT6A and KAT6B as epigenetic drug targets and provides a robust framework for dissecting oncogene-induced senescence mechanisms.

• Pertussis Toxin: Optimizing Immune Modulation Assays in Rese

  2026-06-11

  Pertussis toxin, a potent AB5-type protein exotoxin, is a cornerstone for dissecting immune response modulation and cAMP signaling in translational immunology. This guide delivers actionable workflows, troubleshooting tactics, and evidence-driven protocol enhancements, connecting bench protocols to the latest breakthroughs in TH17 research.

• CMA Decline in Skeletal Muscle Drives Age-Related Myopathy

  2026-06-11

  This study reveals that chaperone-mediated autophagy (CMA) activity declines with age in skeletal muscle, leading to impaired calcium handling and progressive myopathy. By employing innovative genetic models and in vivo reporters, the research clarifies CMA's essential role in muscle homeostasis, offering new directions for targeting age-related muscle degeneration.

• MG-262 (Z-Leu-Leu-Leu-B(OH)2): Precision in Proteasome Inhib

  2026-06-10

  Explore how MG-262 (Z-Leu-Leu-Leu-B(OH)2) enables advanced proteasome inhibition studies and uniquely informs on BIRC2/BIRC3 regulation in cell signaling and apoptosis research. Gain deep scientific insights and practical assay guidance beyond standard protocols.

• Deferoxamine Mesylate: Iron-Chelating Agent for Translationa

  2026-06-10

  Deferoxamine mesylate stands apart as an iron-chelating agent that not only suppresses iron-catalyzed oxidative stress and modulates HIF-1α but also enables precise modeling of hypoxia and ferroptosis for advanced cancer and tissue regeneration studies. This guide details optimized workflows, troubleshooting insights, and translational strategies, linking the latest mechanistic breakthroughs to actionable experimental design.

• Advances in Oudemansiella raphanipies Polysaccharide Extract

  2026-06-09

  This study presents a systematic investigation into the extraction, structural characterization, functional properties, and oral absorption behavior of polysaccharides from Oudemansiella raphanipies. Optimized ultrasonic-assisted extraction and near-infrared fluorescence imaging reveal high bioactivity and promising prebiotic potential, informing future applications in functional foods and bioactive compound research.

• ABCC10-Mediated cGAMP Efflux Drives Radiotherapy Resistance

  2026-06-09

  This study identifies the ATP-dependent transporter ABCC10 as a key mediator of 2'3'-cGAMP efflux in cancer cells, suppressing STING-mediated innate immune responses and contributing to radiotherapy resistance. Targeting ABCC10 may enhance radiosensitivity and inform the development of new biomarkers and therapeutic strategies.

• MitMAB: Precision Tool for Organoid Endocytosis Research

  2026-06-08

  MitMAB (N,N,N-trimethyltetradecan-1-aminium bromide) enables researchers to dissect dynamin-dependent endocytosis with unmatched specificity in intestinal organoid models. This guide translates the latest reference-driven advances into actionable workflows and troubleshooting strategies for membrane trafficking and cellular uptake studies.

• BMS 309403: Optimizing FABP4 Inhibition in Atherosclerosis R

  2026-06-08

  BMS 309403 stands out as a selective FABP4 inhibitor, enabling precise modulation of lipid metabolism and inflammation in cardiovascular research. This guide translates the latest mechanistic findings into actionable protocols and troubleshooting strategies for both in vitro and in vivo studies.

• Ruxolitinib Phosphate (INCB018424) in Advanced JAK/STAT Rese

  2026-06-07

  Ruxolitinib phosphate (INCB018424) is redefining JAK/STAT pathway modulation for both inflammatory and oncologic models, with new workflows enabling precise control of apoptosis and pyroptosis mechanisms. Recent breakthroughs in mitochondrial dynamics position this selective inhibitor as an indispensable tool for dissecting cytokine signaling in complex disease systems.

• Epoxomicin: Proteasome Inhibition for ER Stress & PQC Insigh

  2026-06-06

  Explore Epoxomicin as a proteasome inhibitor in pioneering protein quality control and ER stress research. This article uniquely connects advanced mechanistic findings on UBR1/UBR2 with practical assay guidance, offering researchers new depth beyond standard protocols.

• CRTC-CREB Axis as a Sensor of Proteotoxic Stress via Proteas

  2026-06-05

  This study reveals that the CRTC-CREB transcriptional axis in Drosophila functions as a sensor for proteotoxic stress, particularly when induced by proteasome inhibitors such as MLN2238. The paper uncovers a conserved mechanism involving ROS/JNK signaling, with implications for neurodegeneration and aging-related protein aggregation disorders.

• Practical Use of EdU Imaging Kits (HF594) for DNA Synthesis

  2026-06-05

  EdU Imaging Kits (HF594) provide a direct, sensitive method for quantifying cell proliferation by detecting newly synthesized DNA, streamlining analysis in both fluorescence microscopy and flow cytometry applications. The kit is best suited for in vitro S-phase detection and should not be used for in vivo assays or protocols incompatible with copper-catalyzed chemistries.

• DCPS Regulates TDP-43-Linked Neurodegeneration via P-Bodies

  2026-06-04

  Ye et al. identify DCPS as a genetic modifier of TDP-43 loss-of-function neurotoxicity, showing that DCPS reduction restores neuronal RNA turnover and survival by regulating P-body-mediated RNA decay. These findings illuminate a previously unrecognized mechanistic axis in ALS/FTD pathogenesis, offering new therapeutic directions for TDP-43 proteinopathies.

• Thapsigargin: Strategic Deployment in Translational Research

  2026-06-04

  Explore how Thapsigargin, a gold-standard SERCA pump inhibitor, empowers translational researchers to dissect calcium signaling, endoplasmic reticulum stress, and apoptosis with unparalleled precision. This thought-leadership article blends mechanistic insight, actionable protocol advice, and a forward-looking strategic vision, drawing from recent peer-reviewed studies and APExBIO’s formulation advances.

463 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page